Form 4 for MYGN MYRIAD GENETICS INC
Accepted 2021-08-25 00:00:00 ET · period of report 2021-08-23 · accession 0001219036-21-000024 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-08-25 | 2021-08-23+ | MYGN | LANCHBURY JERRY S | CSO | S - Sale+OE | $35.32 | -80.0K | 232.6K | -26% | -$2.83M |
| DM | 2021-08-25 | 2021-08-23+ | MYGN | LANCHBURY JERRY S | CSO | M - OptEx | $27.07 | +80.0K | 262.6K | +44% | +$2.17M |
| DM | 2021-08-25 | 2021-08-23+ | MYGN | LANCHBURY JERRY S | CSO | M - OptEx | $0.00 | -80.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-23 | S | D | 10,000 | $35.57 | 232,550 | D | — | — | |
| 2 | Common | Common Stock | 2021-08-23 | M | A | 40,000 | $27.07 | 272,550 | D | — | — | |
| 3 | Common | Common Stock | 2021-08-23 | M | A | 10,000 | $27.07 | 242,550 | D | — | — | |
| 4 | Common | Common Stock | 2021-08-24 | M | A | 30,000 | $27.07 | 262,550 | D | — | — | |
| 5 | Common | Common Stock | 2021-08-24 | S | D | 30,000 | $35.57 | 232,550 | D | — | — | |
| 6 | Common | Common Stock | 2021-08-23 | S | D | 40,000 | $35.07 | 232,550 | D | — | — | |
| 7 | Derivative | Non-Qualified Stock Option (right to buy) | 2021-08-23 | M | D | 40,000 | $0.00 | 30,000 | D | $27.07 · — to 2022-09-12 | 40,000 Common Stock | (F2) The shares subject to this option are fully vested and exercisable. |
| 8 | Derivative | Non-Qualified Stock Option (right to buy) | 2021-08-23 | M | D | 10,000 | $0.00 | 70,000 | D | $27.07 · — to 2022-09-12 | 10,000 Common Stock | (F2) The shares subject to this option are fully vested and exercisable. |
| 9 | Derivative | Non-Qualified Stock Option (right to buy) | 2021-08-24 | M | D | 30,000 | $0.00 | 0 | D | $27.07 · — to 2022-09-12 | 30,000 Common Stock | (F2) The shares subject to this option are fully vested and exercisable. |